Is carotid intervention in trials becoming safer?
Monday, 01 Oct 2012 10:51
Early results from ACST-2 suggest that modern carotid artery stenting and carotid endarterectomy have a low serious morbidity and mortality, according to early results of the Asymptomatic Carotid Surgery Trial 2 (ACST-2).
New developments in retrievable inferior vena cava filters reviewed
Monday, 03 Sep 2012 10:49
The new Crux inferior vena cava filter can be implanted and retrieved safely and shows a low rate of pulmonary embolism, Anthony J Comerota, director, Jobst Vascular Institute, adjunct professor of Surgery, University of Michigan, USA, told delegates at the Vascular Annual Meeting (7–9 June 2012). He spoke about new developments with inferior vena cava filters at the conference in National Harbor, USA.
Is it time to reconsider abdominal aortic aneurysm screening programmes?
CX 34 delegates on Sunday heard a variety of reasons why it might be time to question the very foundations on which national aneurysm screening programmes are based. With a population that lives longer, smokes less and has lower cholesterol levels than in the past, it seems that people are developing abdominal aortic aneurysms later in life. Do we need to raise the age threshold for screening? With all trial evidence so far having studied abdominal aortic aneurysm in men between the ages of 65 and 74, is a policy selecting 65 as the age for screening still valid? Have cardiovascular risk prevention programmes pre-empted national aneurysm screening programmes? What is an optimum rescanning interval?
Poštovane kolegice i kolege
obavještavamo Vas da će se od 20. do 22. rujna u Budimpešti održati Treća centralnoeuropska konferencija o neinvazivnom kardiovaskularnom imaging-u.
Više o tome pročitajte na linku Konferencije:
CX symposium 2012
Is the task for TASC III consensus too great?
William Hiatt and Lars Norgren
Preparations for TASC III, which seeks to achieve transatlantic and interdisciplinary consensus, are underway. Saturday’s plenary session at CX 34 saw experts from a variety of disciplines thrash out the challenges that beset TASC IIb, and outline what could be achieved with its successor. Some speakers taking to the podium challenged the notion of whether these guidelines are based on scientific evidence or expert opinion, while others questioned the validity of anatomical treatment recommendations as well as discussed how to balance the importance of consensus in the absence of high-grade scientific evidence. Johannes Lammer, Vienna, Austria, and Roger Greenhalgh, London, UK, chaired the session in which the majority of the audience felt that the TASC III was attempting to consider too many eventualities.
Dragi studenti medicine
Svake godine CIRSE subvencionira dio troškova odlaska na kongres studentima s posebnim interesom za intervencijsku radiologiju. Ove godine taj najveći kongres intervencijske radiologije u EU održati će se u rujnu u Lisabonu. Zahvaljujući našoj Sekciji stipendije su odobrene i za studente medicine u Hrvatskoj.
Više saznajte na web stranici:
Co-investigators Sahil Parikh, Michael Cunningham and Vikram Kashyap, with UH Harrington-McLaughlin
Heart & Vascular Institute at UH Case Medical Center, were the first physicians to successfully implant the
device in a patient.
Stranica 3 od 13